One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study

B. Glintborg; I.J. Sørensen; E. Omerovic; F. Mehnert; N. Manilo; K. Danebod; D.V. Jensen; H. Nordin; A.G. Loft; O. Hendricks; S. Chrysidis; B.L. Andersen; J.L. Raun; H. Lindegaard; J. Espesen; S.H. Jakobsen; I.M.J. Hansen; E.B. Dalsgaard; D.D. Pedersen; S. Kristensen; A. Linauskas; L.S. Andersen; J. Grydehøj; N.S. Krogh; M.L. Hetland

doi:10.1136/annrheumdis-2018-eular.2296

One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study

B. Glintborg, I.J. Sørensen, E. Omerovic, F. Mehnert, N. Manilo, K. Danebod, D.V. Jensen, H. Nordin, A.G. Loft, O. Hendricks, S. Chrysidis, B.L. Andersen, J.L. Raun, H. Lindegaard, J. Espesen, S.H. Jakobsen, I.M.J. Hansen, E.B. Dalsgaard, D.D. Pedersen, S. KristensenA. Linauskas, L.S. Andersen, J. Grydehøj, N.S. Krogh, M.L. Hetland

Department of Clinical Medicine

Original language	English
Article number	FRI0103
Journal	Annals of the Rheumatic Diseases
Volume	77
Issue number	Suppl 2
Number of pages	2
ISSN	0003-4967
DOIs	https://doi.org/10.1136/annrheumdis-2018-eular.2296
Publication status	Published - 2018

Access to Document

10.1136/annrheumdis-2018-eular.2296

595.2.full.pdfFinal published version, 402 KB

Cite this

Glintborg, B., Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Loft, A. G., Hendricks, O., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. M. J., Dalsgaard, E. B., Pedersen, D. D., ... Hetland, M. L. (2018). One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study. Annals of the Rheumatic Diseases, 77(Suppl 2), [FRI0103]. https://doi.org/10.1136/annrheumdis-2018-eular.2296

One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator : an observational danbio study. / Glintborg, B.; Sørensen, I.J.; Omerovic, E. et al.

In: Annals of the Rheumatic Diseases, Vol. 77, No. Suppl 2, FRI0103, 2018.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Glintborg, B, Sørensen, IJ, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Jensen, DV, Nordin, H, Loft, AG, Hendricks, O, Chrysidis, S, Andersen, BL, Raun, JL, Lindegaard, H, Espesen, J, Jakobsen, SH, Hansen, IMJ, Dalsgaard, EB, Pedersen, DD, Kristensen, S, Linauskas, A, Andersen, LS, Grydehøj, J, Krogh, NS & Hetland, ML 2018, ' One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study', Annals of the Rheumatic Diseases, vol. 77, no. Suppl 2, FRI0103. https://doi.org/10.1136/annrheumdis-2018-eular.2296

Glintborg B, Sørensen IJ, Omerovic E, Mehnert F, Manilo N, Danebod K et al. One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study. Annals of the Rheumatic Diseases. 2018;77(Suppl 2):FRI0103. doi: 10.1136/annrheumdis-2018-eular.2296

@article{9f88962c88874020a393a0f88ebccfe7,

title = " One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational danbio study",

author = "B. Glintborg and I.J. S{\o}rensen and E. Omerovic and F. Mehnert and N. Manilo and K. Danebod and D.V. Jensen and H. Nordin and A.G. Loft and O. Hendricks and S. Chrysidis and B.L. Andersen and J.L. Raun and H. Lindegaard and J. Espesen and S.H. Jakobsen and I.M.J. Hansen and E.B. Dalsgaard and D.D. Pedersen and S. Kristensen and A. Linauskas and L.S. Andersen and J. Grydeh{\o}j and N.S. Krogh and M.L. Hetland",

year = "2018",

doi = "10.1136/annrheumdis-2018-eular.2296",

language = "English",

volume = "77",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl 2",

}

TY - ABST

T1 - One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator

T2 - an observational danbio study

AU - Glintborg, B.

AU - Sørensen, I.J.

AU - Omerovic, E.

AU - Mehnert, F.

AU - Manilo, N.

AU - Danebod, K.

AU - Jensen, D.V.

AU - Nordin, H.

AU - Loft, A.G.

AU - Hendricks, O.

AU - Chrysidis, S.

AU - Andersen, B.L.

AU - Raun, J.L.

AU - Lindegaard, H.

AU - Espesen, J.

AU - Jakobsen, S.H.

AU - Hansen, I.M.J.

AU - Dalsgaard, E.B.

AU - Pedersen, D.D.

AU - Kristensen, S.

AU - Linauskas, A.

AU - Andersen, L.S.

AU - Grydehøj, J.

AU - Krogh, N.S.

AU - Hetland, M.L.

PY - 2018

Y1 - 2018

U2 - 10.1136/annrheumdis-2018-eular.2296

DO - 10.1136/annrheumdis-2018-eular.2296

M3 - Conference abstract in journal

SN - 0003-4967

VL - 77

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - Suppl 2

M1 - FRI0103

ER -